Hong Kong Hot Stock: Comprehensive Analysis of Gansu Longshenrongfa Biotech (02367.HK)

This analysis is based on the popular Hong Kong stock Gansu Longshenrongfa Biotech (02367.HK) reported on the East Money App Hong Kong Stock Hot List (Tushare dc_hot) [1]. According to Yahoo Finance data integrated from Ginlix InfoFlow’s internal database [0], the current price of the stock is HK$36.18, down 0.60% on the day; the 52-week price range is HK$35.14-HK$87.10, and the current price is close to the 52-week low. The company’s market capitalization is approximately HK$38.301 billion, with a price-to-earnings ratio (P/E) of 14.77, which is at a relatively low level; the beta coefficient is 0.62, indicating that its price volatility is less than the overall market. In terms of trading volume, the volume on that day was 6.59 million shares, lower than the average volume of 12.55 million shares, showing low market participation. Year-to-date, the stock has a return of -40.88%. Recent news shows that in early December, several large banks lowered their target prices for the stock, but most still maintained “Buy” or “Outperform” ratings, and the trading volume on that day was below average [0].

1. Divergence Between Hot List Performance and Fundamentals
   : Although Gansu Longshenrongfa Biotech (02367.HK) has seen a significant decline in YTD return (-40.88% [0]), it still ranks on the East Money App Hong Kong Stock Hot List, possibly due to continued support from analyst ratings (most maintain Buy/Outperform [0]), reflecting market attention to its long-term prospects.
2. Value Attributes and Low Volatility Characteristics
   : The relatively low P/E ratio (14.77 [0]) makes it attractive to value investors; the beta coefficient of 0.62 [0] means its price volatility is lower than the overall market, suitable for investors with lower risk appetite.
3. Volume Signal Requires Attention
   : The trading volume on that day was below average [0], which may reflect market观望态度 (wait-and-see attitude) towards the current trend of the stock, and subsequent changes in volume may become an important indicator to judge the shift in market sentiment.

• Short-term Price Pressure
  : The significant decline YTD (-40.88% [0]) and the lowering of target prices by several banks in early December [0] may make some investors cautious.
• Liquidity Risk
  : The trading volume on that day was below average [0]; if this situation persists, it may affect the liquidity and trading efficiency of the stock.

• Value Investment Opportunity
  : The relatively low P/E ratio (14.77 [0]) provides a layout opportunity for value investors.
• Institutional Rating Support
  : Most banks maintain “Buy” or “Outperform” ratings [0], indicating institutional confidence in its long-term fundamentals.
• Low Volatility Allocation Value
  : The low beta coefficient [0] makes it suitable for risk-averse investors as a portfolio stabilizer.

As a hot Hong Kong stock on the East Money App [1], Gansu Longshenrongfa Biotech (02367.HK) currently trades close to its 52-week low with a YTD return of -40.88% [0]. The company’s fundamental indicators show a market capitalization of approximately HK$38.301 billion, a P/E ratio of 14.77, and a beta coefficient of 0.62 [0]. Recent trading volume is below average, and several banks have lowered their target prices but most maintain Buy/Outperform ratings [0]. This report only provides market performance and fundamental background of the stock; investors should make decisions based on their own investment strategies and risk preferences, and the content does not constitute investment advice.